Skip to main
NGVT

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp exhibits a positive outlook due to its strategic asset sale, which aims to enhance its portfolio by minimizing operational complexities. This initiative is expected to lead to a reduction in earnings volatility while simultaneously improving the margin profile of the business. Overall, the company is positioned for growth as it capitalizes on execution improvements in its primary revenue-generating segments.

Bears say

Ingevity Corp's outlook is negatively influenced by potential declines in global auto production, as a second downturn could hinder its ability to transition its customer base towards advanced functional additives (AFA), leading to decreased earnings and a significant hit to its valuation multiples. The company operates under a low margin environment, with anticipated margins in the 4-5% range, raising concerns about the sustainability of transaction multiples, especially given that any proceeds might imply multiples higher than prior expectations. Furthermore, various risks, including the impacts of patent cliffs, auto tariffs, weather-related delays in road paving, and competitive pressures in the market, could further threaten the profitability of its Performance Materials and other segments.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.